Abstract

Neuromodulators at the periphery, such as neuromuscular electrical stimulation (NMES), have been developed as add-on tools to regain upper extremity (UE) paresis after stroke, but this recovery has often been limited. To overcome these limits, novel strategies to enhance neural reorganization and functional recovery are needed. This review aims to discuss possible strategies for enhancing the benefits of NMES. To date, NMES studies have involved some therapeutic concerns that have been addressed under various conditions, such as the time of post-stroke and stroke severity and/or with heterogeneous stimulation parameters, such as target muscles, doses or durations of treatment and outcome measures. We began by identifying factors sensitive to NMES benefits among heterogeneous conditions and parameters, based on the “progress rate (PR)”, defined as the gains in UE function scores per intervention duration. Our analysis disclosed that the benefits might be affected by the target muscles, stroke severity and time period after stroke. Likewise, repetitive peripheral neuromuscular magnetic stimulation (rPMS) is expected to facilitate motor recovery, as already demonstrated by a successful study. In parallel, our efforts should be devoted to further understanding the precise neural mechanism of how neuromodulators make UE function recovery occur, thereby leading to overcoming the limits. In this study, we discuss the possible neural mechanisms.

Highlights

  • Stroke is a leading cause of disability, with a greater incidence in older age groups

  • The superiority of neuromuscular electrical stimulation (NMES) compared to standard care was still reportedly controversial [10], perhaps because of a lack of optimal treatment parameters for NMES application. To determine whether these factors may influence motor recovery, we focus on the “progress rate (PR)” as an index of gains, defined as the gains in UE function scores (Fugl–Meyer upper extremity scores) divided by treatment duration

  • Significant improvement in Exp/FMA Before treatment (p = 0.05) 4 weeks (p = 0.05) 12 weeks (p = 0.06) No significant difference was found in FIM Significant improvement in Exp Isometric strength of wrist extensors (4 weeks; p = 0.004, 32 weeks; p = 0.014) ARAT (4 weeks-Grasp/Grip; p = 0.013, 32 weeks-Grasp/Grip; p = 0.02)

Read more

Summary

Introduction

Stroke is a leading cause of disability, with a greater incidence in older age groups. Poststroke disabilities affect upper extremity (UE) function. More severe UE paresis in patients with stroke more profoundly impairs the performance of daily living activities. Full recovery from UE paresis for all survivors is the ultimate goal during rehabilitation intervention. Neuromodulators at the periphery, such as neuromuscular electrical stimulation (NMES), or neuromodulators over the skull, such as repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current electrical stimulation (t-DCS), have been proven to be useful tools for treating UE paresis after a stroke [1,2,3,4,5,6]. We focus on neuromodulators at the periphery

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call